Prediction markets now let users bet on drug trials
Betting platforms known for politics and sports wagers now accept bets on clinical trial results, raising ethical concerns.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Prediction markets now offer wagers on the outcomes of drug trials and regulatory approvals. The Hastings Center for Bioethics has raised ethical concerns about allowing these bets. Reports warn the practice could harm people taking part in trials and reduce access to medicines.
Timeline
- Oct 13, 6:39 PM ET: Prediction markets were reported to offer chances to wager on drug trials and regulatory approvals.
- Oct 16, 9:16 AM ET: The Hastings Center for Bioethics criticized prediction market platforms for letting users bet on clinical trial outcomes.
Coverage
- Dear Kalshi: Stay out of Biopharma : The Hastings Center for Bioethics (thehastingscenter.org)
- How prediction markets could distort drug approvals (thebulletin.org)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials